Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.045 USD | +2.75% | +4.36% | -22.50% |
Apr. 10 | Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer | CI |
Mar. 27 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.50% | 318M | |
+2.01% | 42.75B | |
+47.58% | 41.61B | |
+12.20% | 41.34B | |
-12.36% | 26.59B | |
+8.10% | 25.49B | |
-23.23% | 18.12B | |
+30.62% | 12.24B | |
-2.13% | 11.76B | |
+8.11% | 11B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $5.50 From $8, Maintains Neutral Rating